New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians

por Aguilar Diaz, Jessica M, Abulfathi, Ahmed A, te Brake, Lindsey HM, van Ingen, Jakko, Kuipers, Saskia, Magis-Escurra, Cecile, Raaijmakers, Jelmer, Svensson, Elin M, Boeree, Martin J
Publicado 2023

Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients

por te Brake, Lindsey H.M., Yunivita, Vycke, Livia, Resvi, Soetedjo, Nanny, van Ewijk‐Beneken Kolmer, Eleonora, Koenderink, Jan B., Burger, David M., Santoso, Prayudi, van Crevel, Reinout, Alisjahbana, Bachti, Aarnoutse, Rob E., Ruslami, Rovina
Publicado 2018

Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(−1) rifampicin

por te Brake, Lindsey H.M., de Jager, Veronique, Narunsky, Kim, Vanker, Naadira, Svensson, Elin M., Phillips, Patrick P.J., Gillespie, Stephen H., Heinrich, Norbert, Hoelscher, Michael, Dawson, Rodney, Diacon, Andreas H., Aarnoutse, Rob E., Boeree, Martin J.
Publicado 2021

High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)

por Marais, Suzaan, Cresswell, Fiona V, Hamers, Raph L., te Brake, Lindsey H.M., Ganiem, Ahmad R., Imran, Darma, Bangdiwala, Ananta, Martyn, Emily, Kasibante, John, Kagimu, Enock, Musubire, Abdu, Maharani, Kartika, Estiasari, Riwanti, Kusumaningrum, Ardiana, Kusumadjayanti, Nadytia, Yunivita, Vycke, Naidoo, Kogieleum, Lessells, Richard, Moosa, Yunus, Svensson, Elin M., Huppler Hullsiek, Katherine, Aarnoutse, Rob E., Boulware, David R., van Crevel, Reinout, Ruslami, Rovina, Meya, David B.
Publicado 2020